Tamsulosin for Preventing Catheter Use After Urogynecology Surgery
This study is looking into whether taking tamsulosin before certain urogynecology surgeries can lower your chances of needing a Foley catheter (a flexible tube that drains urine from the bladder) when you go home. Researchers will compare tamsulosin to a placebo (an inactive substance) to see if tamsulosin helps prevent postoperative urinary retention (POUR). You may be able to join if you are a woman aged 18 or older having surgery for pelvic organ prolapse or incontinence. The main goal is to see if participants can successfully urinate on their own on the day of surgery. The current status of this study is unclear, and it plans to enroll 166 participants.
- Study design
- This interventional study is designed to compare tamsulosin to a placebo in 166 women.
- What's involved
- If you join, you would start taking either tamsulosin or a placebo 5-7 days before your surgery. The study will assess your ability to urinate on the day of surgery.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary outcome is measured on the day of surgery.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Exclusion
What this trial measures
- Voiding trial on postoperative day 0Day of surgery
Whether or not patients pass or fail their postoperative voiding trial